Paresh Vyas, MRCP, FRCP, FRCPath is a Professor of Hematology at the Weatherall Institute of Molecular Medicine at the University of Oxford in Oxford, UK. He studied for his medical degree at the University of Cambridge in Cambridge, UK and the University of Oxford. He received his doctorate from the MRC Molecular Hematology Unit at the University of Oxford. Prof. Vyas then completed a post-doctoral fellowship at Harvard University in Boston, MA.
Prof. Vyas is a member of the UK AML and MDS clinical trial groups and is co-Lead of the Oxford BRC Haematology and Stem Cells Theme. He is a member of the board of NHSBT, vice-chair of the MRC Clinical Training Panel and Translational Lead for the UK Therapy Acceleration Program.
Speaking on targeting myeloid stem cells for MDS and AML
Prof. Vyas’ research focuses on myeloid disorders, including myelodysplastic syndromes (MDS), acute myeloid leukemia (AML) and myeloproliferative disorders. He is also interested in allogenic stem cell transplantation. Much of his research investigates the biology of AML and MDS, with a particular focus on purification and targeting of myeloid stem cells.